Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-01-05

Clinical Trial Update: Fecal Microbial Transplantation and Fiber Supplementation in Participants With Obesity and Metabolic Syndrome. [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating fecal microbial transplantation with fiber supplementation in adults with obesity and metabolic syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Alberta | Conditions: Obesity, Metabolic Syndrome | Phase 2 | Status: COMPLETED